Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli et al
- PMID: 32451345
- DOI: 10.1136/annrheumdis-2020-217859
Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli et al
Keywords: autoimmune diseases; hydroxychloroquine; lupus erythematosus, systemic.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Are patients with systemic lupus erythematosus at increased risk for COVID-19?Ann Rheum Dis. 2021 Feb;80(2):e25. doi: 10.1136/annrheumdis-2020-217787. Epub 2020 May 25. Ann Rheum Dis. 2021. PMID: 32451344 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
